Showing results (61-70 of 177) with videos related to
Sort By:
Pageof 18
Molecular Cancer Research : MCR|June 1, 2013
HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RASMoon Hee Yang, Gaelle Laurent, Alexandra S Bause, et al.Nature Chemical Biology|July 3, 2023
Discovery of VH domains that allosterically inhibit ENPP1Paige E Solomon, Colton J Bracken, Jacqueline A Carozza, et al.Research Square|July 3, 2023
FET fusion oncoproteins disrupt physiologic DNA repair networks and induce ATR synthetic lethality in cancerShruti Menon, Marcus R Breese, Yone Phar Lin, et al.Cancer Cell|October 13, 2020
Advances and Challenges in Pediatric and Childhood CancersCynthia Hawkins, Stefan Pfister, David T W Jones, et al.Cancer Research|March 22, 2014
A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinomaRon Chen, Purvesh Khatri, Pawel K Mazur, et al.Cell Death & Disease|January 25, 2019
Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcomaSuchismita Mohanty, Ketan Yerneni, Johanna Lena Theruvath, et al.Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
HIF-2alpha deletion promotes Kras-driven lung tumor developmentJolly Mazumdar, Michele M Hickey, Dhruv K Pant, et al.Journal of Pediatric Hematology/Oncology|August 21, 2020
NUP98-NSD1 Driven MDS/MPN in Childhood Masquerading as JMMLAstrid Behnert, Alex G Lee, Elizabeth P Young, et al.Cancer Discovery|October 2, 2025
Epigenetic and transcriptional programs define osteosarcoma subtypes and establish targetable vulnerabilitiesEunice Lopez-Fuentes, Andrew S Clugston, Alex G Lee, et al.Cancer Reports (Hoboken, N.J.)|November 7, 2023
Pre-and post-HSCT use of TKI therapy for fusion-driven B-ALL: A case series of five pediatric, adolescent and young adult patientsSavannah S Shumock, William C Temple, Amanda Marinoff, et al.Pageof 18